summary
Introduced
01/29/2020
01/29/2020
In Committee
02/18/2020
02/18/2020
Crossed Over
02/14/2020
02/14/2020
Passed
02/20/2020
02/20/2020
Dead
Signed/Enacted/Adopted
02/20/2020
02/20/2020
Introduced Session
2020 Regular Session
Bill Summary
AN ACT RELATING TO HEALTH CARE PLANS; ESTABLISHING LIMITS ON COST SHARING FOR CERTAIN PRESCRIPTION DRUGS; REQUIRING A REPORT RECOMMENDING ADDITIONAL DRUGS AND SERVICES FOR COST-SHARING LIMITATIONS; REQUIRING A STUDY OF THE COST OF PRESCRIPTION DRUGS FOR NEW MEXICO CONSUMERS AND MAKING RECOMMENDATIONS ON INCREASING ACCESSIBILITY OF PRESCRIPTION DRUGS; AMENDING AND ENACTING SECTIONS OF THE NMSA 1978.
AI Summary
This bill establishes limits on cost sharing for certain prescription drugs, specifically capping the total amount an insured must pay for prescription insulin drugs at $50 per 30-day supply. It also requires the superintendent of insurance to convene an advisory group to study the cost of prescription drugs for New Mexico consumers and make recommendations on increasing accessibility of certain medications, including those used for asthma, diabetes, allergies, hypertension, mental health, and other conditions. The bill aims to improve affordability and access to essential prescription drugs for New Mexicans.
Committee Categories
Government Affairs
Sponsors (2)
Last Action
Signed by Governor - Chapter 36 - Mar. 4 (on 02/20/2020)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nmlegis.gov/lcs/legislation.aspx?chamber=H&legtype=B&legno=292&year=20 |
| BillText | https://www.nmlegis.gov/Sessions/20%20Regular/final/HB0292.pdf |
| BillText | https://www.nmlegis.gov/Sessions/20%20Regular/bills/house/HB0292.pdf |
Loading...